\
&
Contact us
\
&
Contact us
AP Hogeschool Antwerpen - research@ap.be - 03/220 56 49
Arteveldehogeschool Gent - EU-research@arteveldehs.be - 09/234 91 68 or 09/234 91 16
Flanders Make - Ger van den Kerkhof - 011/ 79 05 60
Hogeschool Gent - onderzoek@hogent.be - 09/243 32 84
ILVO - Cathy Plasman - 09/272 25 31
IMEC - Anne.vandenbosch@imec.be - 016/281 682
INBO - evinbo@inbo.be - 0474/29 84 24
Instituut voor Tropische Geneeskunde - research@itg.be - 03/247 66 86
KU Leuven Idea>proposal - Eu-info@kuleuven.be - 016/320 944-446
KU Leuven Proposal>Project - Lrd.eu@kuleuven.be - 016/320 631-621
LUCA School of Arts - matthias.somers@luca-arts.be - 02/447 18 42
Odisee vzw - Willem vanden Berg - 09/267 27 14
UCLL - Research.expertise@ucll.be - 011/180 900
Universiteit Antwerpen - research@uantwerpen.be - 03/265 30 02
Universiteit Gent - EU-team@ugent.be - 09/264 3029
Universiteit Hasselt - Euresearch@uhasselt.be - 011/268050 - 9043
VIB - Lieve.ongena@vib.be - 09/244 66 11
VITO - EU-liaison@vito.be - 014/335 669
VIVES Hogeschool - Elke Denys - 056/28 06 29
Vrije Universiteit Brussel - elo@vub.be - 02/629 2210
Throughout Flanders, several Flemish institutes offer support services for European funding for research and innovation, also known as the European Liaison offices.
The list here is non-exhaustive and being continuously updated. In case your institute would like to be included on this page please send a message to info@ncpflanders.be.
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
